Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Epilepsia Open|March 29, 2018
The intrahippocampal kainate mouse model of mesial temporal lobe epilepsy: Lack of electrographic seizure-like events in sham controlsFriederike Twele, Alina Schidlitzki, Kathrin Töllner, et al.
Epilepsia|December 13, 2019
A face-to-face comparison of the intra-amygdala and intrahippocampal kainate mouse models of mesial temporal lobe epilepsy and their utility for testing novel therapiesLisa Welzel, Alina Schidlitzki, Friederike Twele, et al.
Frontiers in Cell and Developmental Biology|December 7, 2020
Current Evidence for a Bidirectional Loop Between the Lysosome and Alpha-Synuclein ProteoformsNorelle C Wildburger, Anna-Sophia Hartke, Alina Schidlitzki, et al.
Journal of Parkinson'S Disease|February 20, 2025
Alterations in non-REM sleep and EEG spectra precede REM-sleep deficits in a model of synucleinopathyChristopher Käufer, Miloš Stanojlović, Alina Schidlitzki, et al.
Epilepsy Research|March 5, 2019
Network pharmacology for antiepileptogenesis: Tolerability and neuroprotective effects of novel multitargeted combination treatments in nonepileptic vs. post-status epilepticus miceLisa Welzel, Friederike Twele, Alina Schidlitzki, et al.
Epilepsy Research|November 25, 2015
Network pharmacology for antiepileptogenesis: Tolerability of multitargeted drug combinations in nonepileptic vs. post-status epilepticus miceRebecca Klee, Kathrin Töllner, Vladan Rankovic, et al.
Epilepsia|February 28, 2016
The bumetanide prodrug BUM5, but not bumetanide, potentiates the antiseizure effect of phenobarbital in adult epileptic miceThomas Erker, Claudia Brandt, Kathrin Töllner, et al.
Neurobiology of Disease|December 21, 2020
Systematic evaluation of rationally chosen multitargeted drug combinations: a combination of low doses of levetiracetam, atorvastatin and ceftriaxone exerts antiepileptogenic effects in a mouse model of acquired epilepsyLisa Welzel, David H Bergin, Alina Schidlitzki, et al.
Neuropharmacology|October 27, 2019
Selective inhibition of mTORC1/2 or PI3K/mTORC1/2 signaling does not prevent or modify epilepsy in the intrahippocampal kainate mouse modelBirthe Gericke, Claudia Brandt, Wiebke Theilmann, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 13, 2023
Double-Edged Effects of Venglustat on Behavior and Pathology in Mice Overexpressing α-SynucleinAlina Schidlitzki, Milos Stanojlovic, Céline Fournier, et al.
Pageof 2